Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 1/20 | 0.64 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.64 |
| ▸ | CA12 | O43570 | 1/20 | 0.62 |
| ▸ | CA1 | P00915 | 1/20 | 0.62 |
| ▸ | CA2 | P00918 | 1/20 | 0.62 |
| ▸ | CA9 | Q16790 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | UNG | P13051 | 1/20 | 0.52 |
| ▸ | BRD4 | O60885 | 1/20 | 0.52 |
| ▸ | CDK8 | P49336 | 1/20 | 0.51 |
| ▸ | SRC | P12931 | 1/20 | 0.45 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.44 |
| ▸ | DYRK2 | Q92630 | 2/20 | 0.44 |
| ▸ | DYRK1B | Q9Y463 | 2/20 | 0.44 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.44 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.44 |
| ▸ | CDK9 | P50750 | 1/20 | 0.44 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27621710 | 0.97 | TRIM24 (0.68) | TRIM24TRIM33CA12CA1CA2 | |
| SCHEMBL11770226 | 0.95 | TRIM24 (0.71) | TRIM24TRIM33CA12CA1CA2 | |
| SCHEMBL31313039 | 0.95 | TRIM24 (0.60) | TRIM24TRIM33CA12CA1CA2 | |
| SCHEMBL18223050 | 0.93 | TRIM24 (0.58) | TRIM24TRIM33CA12CA1CA2 | |
| SCHEMBL97618 | 0.93 | TRIM24 (0.69) | TRIM24TRIM33CA12CA1CA2 | |
| SCHEMBL29414645 | 0.93 | TRIM24 (0.69) | TRIM24TRIM33CA12CA1CA2 | |
| SCHEMBL5916092 | 0.91 | TRIM24 (0.67) | TRIM24TRIM33CA12CA1CA2 | |
| SCHEMBL29700451 | 0.91 | TRIM24 (0.67) | TRIM24TRIM33CA12CA1CA2 | |
| SCHEMBL28460866 | 0.91 | TRIM24 (0.67) | TRIM24TRIM33CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL7795298 | 0.89 | TRIM24 (0.65) | TRIM24TRIM33CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118931123-B | Flame-retardant high-strength PET composite material and preparation process thereof | 广东君邦新材料科技有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-118931123-A | Flame-retardant high-strength PET composite material and preparation process thereof | 广东君邦新材料科技有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-118491491-A | Preparation and application of hydroxylation magnetic covalent organic framework material | 中国检验检疫科学研究院 | 2024-08-16 | — | — | CN | claimed |
| CN-118931123-B | Flame-retardant high-strength PET composite material and preparation process thereof | 广东君邦新材料科技有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-118931123-A | Flame-retardant high-strength PET composite material and preparation process thereof | 广东君邦新材料科技有限公司 | 2024-11-12 | — | — | CN | disclosed |
| US-20240342062-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-10-17 | — | — | US | disclosed |
| CN-118491491-A | Preparation and application of hydroxylation magnetic covalent organic framework material | 中国检验检疫科学研究院 | 2024-08-16 | — | — | CN | disclosed |
| WO-2023250518-A2 | CATALYST FOR POLYMERIZATION OF CYCLIC ETHER AND CYCLIC ESTER MONOMERS AND THE RESULTING POLYMERS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| US-11767389-B2 | Crosslinking agent and fluorine-containing aromatic compound | NICHIAS CORPORATION (JP) | 2023-09-26 | — | — | US | disclosed |
| CN-111116528-B | Method for producing aromatic primary diamine | 罗地亚经营管理公司 | 2023-08-01 | — | — | CN | disclosed |
| CN-116457084-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2023-07-18 | — | — | CN | disclosed |
| WO-2010063461-A1 | BRIDGED PYRIDOQUINAZOLINE OR PHENANTHROLINE COMPOUNDS AND ORGANIC SEMICONDUTING MATERIAL COMPRISING THAT COMPOUND | NOVALED AG (DE) | 2010-06-10 | — | — | WO | disclosed |
| WO-2010063461-A1 | BRIDGED PYRIDOQUINAZOLINE OR PHENANTHROLINE COMPOUNDS AND ORGANIC SEMICONDUTING MATERIAL COMPRISING THAT COMPOUND | NOVALED AG (DE) | 2010-06-10 | — | — | WO | disclosed |
| EP-2194055-A1 | Bridged pyridoquinazoline or phenanthroline compounds and organic semiconducting material comprising that compound | Novaled AG (DE) | 2010-06-09 | — | — | EP | disclosed |
| EP-2194055-A1 | Bridged pyridoquinazoline or phenanthroline compounds and organic semiconducting material comprising that compound | Novaled AG (DE) | 2010-06-09 | — | — | EP | disclosed |
| JP-2007015925-A | METHOD FOR PRODUCING DIVINYLBIPHENYL | MATSUSHITA ELECTRIC IND CO LTD | 2007-01-25 | — | — | JP | disclosed |
| WO-2005003068-A1 | PROCESS FOR PRODUCING DIVINYLBIPHENYL AND DIVINYLBIPHENYL | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2005-01-13 | — | — | WO | disclosed |
| US-6780561-B2 | FOR FORMING PROTECTIVE FILM OR AN INSULATING FILM FOR A SEMICONDUCTOR ELEMENT OR A CIRCUIT BOARD SUCH AS A PRINTED BOARD | KANSAI PAINT CO., LTD. (JP) | 2004-08-24 | — | — | US | disclosed |
| US-20030143480-A1 | For forming protective film or an insulating film for a semiconductor element or a circuit board such as a printed board | KANSAI PAINT CO., LTD. (JP) | 2003-07-31 | — | — | US | disclosed |
| US-6177500-B1 | CONTAINING A P-OXYBENZOYL UNIT (A) AND A 4'-OXYBIPHENYL-4-CARBONYL UNIT (B) AND 1 TO 400 PARTS BY WEIGHT OF AN INORGANIC FILLER. | SUMITOMO CEMICAL COMPANY, LIMITED (JP) | 2001-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11767389-B2 | Crosslinking agent and fluorine-containing aromatic compound | AFF1, H1-3, AFF4 | TRIM24 481/4885TRIM33 636/4885CA12 3330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.